Ibritumomab Tiuxetan and Levalbuterol Inhalation Solution Concentrate
Determining the interaction of Ibritumomab Tiuxetan and Levalbuterol Inhalation Solution Concentrate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab
Generic Name: levalbuterol
Brand name: Xopenex, Xopenex Concentrate, Xopenex HFA
Synonyms: Levalbuterol inhalation, Levalbuterol
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Tiuxetan-Levalbuterol Inhalation, oral/nebulization
- Ibritumomab Tiuxetan-Levamisole
- Ibritumomab Tiuxetan-Levaquin
- Ibritumomab Tiuxetan-Levaquin (Levofloxacin Injection)
- Ibritumomab Tiuxetan-Levaquin (Levofloxacin Oral Solution)
- Ibritumomab Tiuxetan-Levaquin (Levofloxacin Tablets)
- Levalbuterol Inhalation Solution Concentrate-Ibrutinib
- Levalbuterol Inhalation Solution Concentrate-Ibrutinib Capsules
- Levalbuterol Inhalation Solution Concentrate-Ibrutinib Tablets
- Levalbuterol Inhalation Solution Concentrate-Ibu
- Levalbuterol Inhalation Solution Concentrate-IBU Tablets
- Levalbuterol Inhalation Solution Concentrate-Ibu-2